tiprankstipranks
ArriVent announces PoC global Phase 1b interim data for firmonertinib
PremiumThe FlyArriVent announces PoC global Phase 1b interim data for firmonertinib
2M ago
Corbus Pharmaceuticals appoints Kung to board of directors
Premium
The Fly
Corbus Pharmaceuticals appoints Kung to board of directors
3M ago
ArriVent Biopharma price target raised to $30 from $25 at H.C. Wainwright
Premium
The Fly
ArriVent Biopharma price target raised to $30 from $25 at H.C. Wainwright
3M ago
PremiumCompany AnnouncementsArriVent BioPharma Welcomes Dr. Hohneker to Board
6M ago
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
Premium
The Fly
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
7M ago
ArriVent Biopharma initiated with a Buy at H.C. Wainwright
Premium
The Fly
ArriVent Biopharma initiated with a Buy at H.C. Wainwright
7M ago
ArriVent Biopharma initiated with a Buy at Citi
PremiumThe FlyArriVent Biopharma initiated with a Buy at Citi
9M ago
ArriVent Biopharma initiated with a Buy at Goldman Sachs
Premium
The Fly
ArriVent Biopharma initiated with a Buy at Goldman Sachs
9M ago
Opening Day: Chromocell Therapeutics, Unusual Machines make public debut
Premium
The Fly
Opening Day: Chromocell Therapeutics, Unusual Machines make public debut
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100